Treatment update in geriatric psychiatry

Western Journal of Medicine

Volumn 169, Issue 1, 1998, Pages 42-43

  Schneiber, Lon S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; CHOLINESTERASE INHIBITOR; ESTROGEN; FLUOXETINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR;

AGED; ALZHEIMER DISEASE; CLINICAL TRIAL; COMORBIDITY; DAILY LIFE ACTIVITY; DEPRESSION; DRUG EFFICACY; ESTROGEN THERAPY; EXTRAPYRAMIDAL SYMPTOM; GERONTOPSYCHIATRY; HUMAN; MULTIINFARCT DEMENTIA; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; SHORT SURVEY; TARDIVE DYSKINESIA;

EID: 0031850223     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (5)

1. Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Silbersweig D, Charlson M. Clinically defined vascular depression. Am J Psychiatry 1997; 154:562-565
2. Devanand DP, Kim MK, Nobler MS. Fluoxetine discontinuation in elderly dysthymic patients. Am J Geriatr Psychiatry 1997; 5:83-87
3. Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry 1997; 154:497-501
4. Sano M, Ernesto C, Klauber MR, Schafer K, Woodbury P, Thomas R, Grandman M, Growdon J, Cotman CW, Pfeiffer E, Schneider L, Thal L. A controlled trial of selegiline, α-tocopherol or both as treatment for Alzheimer's Disease. N Engl J Med 1997; 336:1216-1222
5. Schneider LS, Farlow MR, Henderson VW, Pogoda JM. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 1996; 46:1580-1584